Digestive Disease Week 2025

Liver outlineA delegation from the Stravitz-Sanyal Institute for Liver Disease and Metabolic Health, led by Institute Director Arun Sanyal, M.D., FAASLD, and Chief Scientific Officer Saul Karpen, M.D., Ph.D., FAASLD, incoming president-elect of AASLD, will attend the DDW meeting in San Diego.

VCU @ DDW day by day

To see the full list of VCU's presence at DDW 2025, select a date below:

Saturday, May 3
Name: ID: Time: Location: Title:
Bajaj 6 8-8:15 a.m. 6C-SDCC INITIATION OF SECONDARY SBP PROPHYLAXIS IN PATIENTS WITH A NEW SBP ASSOCIATES WITH A HIGHER RATE OF NON-SBP INFECTIONS COMPARED TO THOSE NOT STARTED ON IT IN A NATIONAL COHORT OF VETERANS WITH CIRRHOSIS
Arab Sp180 10:21-10:30 a.m. 6F-SDCC CON ARGUMENT W/SLIDES
Arab Sp180 10:37-10:39 a.m. 6F-SDCC COMPREHENSIVE CARE MANAGEMENT OF INDIVIDUALS WITH ALCOHOL USE DISORDER AND ALCOHOL-ASSOCIATED LIVER DISEASE CON REBUTTAL W/O SLIDES
Arab Sp183 10:39-10:52 a.m. 6F-SDCC COMPREHENSIVE CARE MANAGEMENT OF INDIVIDUALS WITH ALCOHOL USE DISORDER AND ALCOHOL-ASSOCIATED LIVER DISEASE AUDIENCE/JUDGES Q&A
Lulkin Sa1662 12:30-1:30 p.m. Halls C-E, Lower Level - SDCC LONG COVID IN PATIENTS WITH FUNCTIONAL AND STRUCTURAL GASTROINTESTINAL CONDITIONS: CONSIDERING GASTROINTESTINAL OUTCOMES PRECEDING AND FOLLOWING POST-COVID-19 SYNDROME
Kumar Sa1667 12:30-1:30 p.m. Halls C-E, Lower Level - SDCC GLOBAL PREVALENCE AND DEMOGRAPHIC VARIABILITY OF POST-COVID-19 IRRITABLE BOWEL SYNDROME: A SYSTEMATIC REVIEW AND META-ANALYSIS
Andrews Sa1674 12:30-1:30 p.m. Halls C-E, Lower Level - SDCC DIARRHEA-PREDOMINANT IRRITABLE BOWEL SYNDROME TREATMENT OPTIONS ELUXADOLINE, RIFAXIMIN, AND ALOSETRON: ANALYSIS OF THE FDA ADVERSE EVENT REPORTING SYSTEM (FAERS) DATABASE
Jahagirdar Sa1820 12:30-1:30 p.m. Sa1820 COMPARISON OF CAPSULE ENDOSCOPY WITH OTHER IMAGING MODALITIES FOR DIAGNOSIS OF SMALL BOWEL CROHN’S DISEASE: A NETWORK META-ANALYSIS
Bajaj Sa1962 12:30-1:30 p.m. Halls C-E, Lower Level - SDCC WIDE VARIATIONS IN ANTIMICROBIAL GENE CARRIAGE IN PATIENTS WITH CIRRHOSIS AND HEALTHY CONTROLS FROM 7 COUNTRIES WITH 1020 PARTICIPANTS: IMPLICATIONS FOR RESISTANT INFECTIONS
Thota Sa2059 12:30-1:30 p.m. Halls C-E, Lower Level - SDCC PREDICTIVE MODELING OF GI DISEASE: GASTROENDO-SEQ FOR PROGRESSION AND OUTCOME FORECASTING
Jahagirdar, H. Ali Sa1461 12:30-1:30 p.m. Halls C-E, Lower Level - SDCC CLINICAL EFFICACY AND SAFETY OF EARLY VERSUS DELAYED INTERVENTION FOR ACUTE NECROTIZING PANCREATITIS, SUBGROUP ANALYSIS WITH INFECTED NECROTIZING PANCREATITIS AND ORGAN FAILURE - A SYSTEMATIC REVIEW AND META-ANALYSIS
Thota Sa2027 12:30-1:30 p.m. Halls C-E, Lower Level - SDCC VISION TRANSFORMER-BASED FRAMEWORK FOR RISK STRATIFICATION AND PROGNOSTIC ASSESSMENT IN GASTROINTESTINAL LESION MANAGEMENT
Kumar Sa1467 12:30-1:30 p.m. Halls C-E, Lower Level - SDCC LONG TERM SURVIVAL IN ACETAMINOPHEN-INDUCED ACUTE LIVER FAILURE WITH CONTINUOUS RENAL REPLACEMENT THERAPY
Baral Sa1546 12:30-1:30 p.m. Halls C-E, Lower Level - SDCC INTERACTION BETWEEN ATHEROGENIC DYSLIPIDEMIA AND METABOLIC DYSFUNCTION ASSOCIATED STEATOTIC LIVER DISEASE IN LIVER TRANSPLANT RECIPIENTS
Jahagirdar Sa1585 12:30-1:30 p.m. Halls C-E, Lower Level - SDCC MASLD INCREASES THE RISK OF PATHOLOGICAL FRACTURES
Thota Sa2060 12:30-1:30 p.m. Halls C-E, Lower Level - SDCC AI-DRIVEN REAL-TIME DETECTION, CLASSIFICATION, AND MALIGNANCY RISK PREDICTION OF COLORECTAL POLYPS USING THE ERCPMP-V5 DATASET
Thota Sa2063 12:30-1:30 p.m. Halls C-E, Lower Level - SDCC UTILIZING VISION TRANSFORMER ARCHITECTURE TO CREATE A MODEL FOR AUTOMATED DETECTION OF SMALL BOWEL LESIONS IN CAPSULE ENDOSCOPY
Thota Sa2023 12:30-1:30 p.m. Halls C-E, Lower Level - SDCC A MACHINE LEARNING FRAMEWORK FOR PREDICTING POLYP EVOLUTION AND MALIGNANCY RISK: ENHANCING PERSONALIZED SURVEILLANCE IN GASTROENTEROLOGY
Asgharpour 2345-Clinical Symposium 2-3:30 p.m. 11-SDCC ACADEMIC DEBATE: ADVANCED ALD AND ALCOHOL-ASSOCIATED HEPATITIS FINDING THE BEST PATH FOR YOUR PATIENT
Sunday, May 4
Name: ID: Time: Location: Title:
Puri, Fuchs 327 9-9:15 a.m. 6F-SDCC PROSPECTIVE UNIVERSAL RISK INSTRUMENT (PURI): A NOVEL PRECISION DIAGNOSTIC TOOL TO ACCURATELY CLASSIFY METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE (MASLD) WITH SIGNIFICANT FIBROSIS
Bajaj Sp479 10:21-10:30 a.m. 8-SDCC STRATEGIES FOR PRIMARY PROPHYLAXIS OF ESOPHAGEAL VARICEAL BLEED IN ADULT AND PEDIATRIC PATIENTS CON REBUTTAL W/SLIDES
Bajaj Sp481 10:21-10:30 a.m. 8-SDCC STRATEGIES FOR PRIMARY PROPHYLAXIS OF ESOPHAGEAL VARICEAL BLEED IN ADULT AND PEDIATRIC PATIENTS CON REBUTTAL W/O SLIDES
Fuchs, Pandak, Puri, Vozzo, Spataro 415

10:48-11:02 a.m.

6C-SDCC MULTISITE PROSPECTIVE EVALUATION OF COMPUTER AIDED DIAGNOSIS FOR REAL TIME OPTICAL DIAGNOSIS OF COLORECTAL POLYPS
Kumar Su1800 12:30-1:30 p.m. Halls C-E, Lower Level-SDCC Su1800: GLOBAL PREVALENCE AND DEMOGRAPHIC VARIABILITY OF POST-COVID FUNCTIONAL DYSPEPSIA: A SYSTEMATIC REVIEW AND META-ANALYSIS
Bajaj, Fagan, Fuchs, Lee, Sterling, Muldowney Gallagher, Matherly, Luketic, Puri, Davis Su2006 12:30-1:30 p.m. Halls C-E, Lower Level-SDCC METABOLOMIC CHANGES AND DONOR ENGRAFTMENT ARE ASSOCIATED WITH REDUCED RECURRENCE OF HEPATIC ENCEPHALOPATHY AFTER FECAL MICROBIOTA TRANSPLANT: THEMATIC RCT ANALYSIS
Smallfield Su1362 12:30-1:30 p.m. Halls C-E, Lower Level-SDCC CONSENSUS RECOMMENDATIONS FOR LIQUID NITROGEN SPRAY CRYOTHERAPY FOR BARRETT’S ESOPHAGUS USING A MODIFIED DELPHI PROCESS
Smallfield Su1363 12:30-1:30 p.m. Halls C-E, Lower Level-SDCC CONSENSUS RECOMMENDATIONS FOR LIQUID NITROGEN SPRAY CRYOTHERAPY FOR ESOPHAGEAL CANCER USING A MODIFIED DELPHI PROCESS
Smallfield Su1363 12:30-1:30 p.m. Halls C-E, Lower Level-SDCC CONSENSUS RECOMMENDATIONS FOR LIQUID NITROGEN SPRAY CRYOTHERAPY FOR ESOPHAGEAL CANCER USING A MODIFIED DELPHI PROCESS
Jahagirdar Su2074 12:30-1:30 p.m. Halls C-E, Lower Level-SDCC ARTIFICIAL INTELLIGENCE (AI) IN GASTROENTEROLOGY (GI): RESULTS FORM A MULTI-CENTER INTERNATIONAL STUDY ASSESSING PATIENT KNOWLEDGE, BELIEFS AND CONCERNS
Arab Su1639 12:30-1:30 p.m. Halls C-E, Lower Level-SDCC ALCOHOL-ASSOCIATED HEPATITIS IN ALCOHOL-ASSOCIATED LIVER DISEASE IS ASSOCIATED WITH INCREASING LIVER TRANSPLANT LISTINGS IN YOUNG AND OBESE CANDIDATES WITH GOOD FUNCTIONAL STATUS AND MELD SCORE
Tariq Su1674 12:30-1:30 p.m. Halls C-E, Lower Level-SDCC DISPARITIES IN RECRUITMENT FOR CLINICAL TRIALS FOCUSED ON LIVER TRANSPLANTATION
Jahagirdar Su1734 12:30-1:30 p.m. Halls C-E, Lower Level-SDCC IMPACT OF HOSPICE UTILIZATION IN ACUTE HOSPITAL CARE OF PATIENTS ADMITTED WITH DECOMPENSATED CIRRHOSIS AND HEPATOCELLULAR CARCINOMA – A SYSTEMATIC REVIEW AND META-ANALYSIS
Arab 3355 2-3:30 p.m. 26-SDCC MASLD-NOVEL INSIGHTS IN DISEASE EPIDEMIOLOGY
Jahagirdar Sp582 2:25-2:40 p.m. 8-SDCC WHY SERIES
Karpen Sp709b 4-4:06 p.m. 6C-SDCC PRESENTATION LIVER & BILIARY (LB) SECTION RESEARCH MENTOR AWARD
Arab 529 4:06-4:20 p.m. 6C-SDCC GENETIC AND CLINICAL PREDICTORS OF MORTALITY IN STEATOTIC LIVER DISEASE: A PROSPECTIVE COHORT STUDY
Fakhoury 617 5:12-5:18 p.m. 9-SDCC THE LARGEST SINGLE-CENTER EXPERIENCE IN ENDOSCOPIC SUBMUCOSAL DISSECTION IN EGYPT: CLINICAL OUTCOMES AND SAFETY
Puri Sp474 10:44-11:06 a.m. 32-SDCC OBESITY DRUGS THAT TREAT AT-RISK MASH – CONSIDERATION FOR OBESITY IN LIVER TRANSPLANT CANDIDATES
Puri 327 9-9:15 a.m. 6F-SDCC PROSPECTIVE UNIVERSAL RISK INSTRUMENT (PURI): A NOVEL PRECISION DIAGNOSTIC TOOL TO ACCURATELY CLASSIFY METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE (MASLD) WITH SIGNIFICANT FIBROSIS
Bajaj, Fagan, Fuchs, Lee, Sterling, Muldowney Gallagher, Matherly, Luketic, Puri, Davis Su2006 12:30-1:30 p.m. Halls C-E, Lower Level-SDCC METABOLOMIC CHANGES AND DONOR ENGRAFTMENT ARE ASSOCIATED WITH REDUCED RECURRENCE OF HEPATIC ENCEPHALOPATHY AFTER FECAL MICROBIOTA TRANSPLANT: THEMATIC RCT ANALYSIS
Szabó Su1522 12:30-1:30 p.m. Halls C-E, Lower Level-SDCC TEST FOR PEDIATRIC PANCREATITIS! – RESULTS OF THE PAIN IN EARLY PHASE OF PEDIATRIC PANCREATITIS (PINEAPPLE) RETROSPECTIVE AND PROSPECTIVE OBSERVATIONAL STUDIES
Monday, May 5
Name: ID: Time: Location: Title:
Arab Sp726a 8:50-9 a.m. 8-SDCC STUMP THE HEPATOLOGIST EXPERT PANEL
Jahagirdar 639 9:15-9:30 a.m. 6C-SDCC A SYSTEMATIC REVIEW AND META-ANALYSIS ON COMPARING OUTCOMES BETWEEN EARLY TIPS WITHIN 72 HOURS AND STANDARD THERAPY
Albhaisi Sp853 11:05-11:25 a.m. 29CD-SDCC TRENDS AND OPPORTUNITIES FOR THE NEXT-GENERATION OF GI PRACTICE PANEL DISCUSSION
Kanak, McClintock, Saravanan, Broomfield, Kalivarathan, Khan Mo1457 12:30-1:30 p.m. Halls C-E, Lower Level-SDCC RACIAL DISPARITIES IN TPIAT: A COMPARATIVE ANALYSIS OF OUTCOMES IN AFRICAN AMERICAN AND CAUCASIAN PATIENTS
Kumar, Mangray, Bickston Mo1843 12:30-1:30 p.m. Halls C-E, Lower Level-SDCC PREGNANCY COMPLICATIONS IN INFLAMMATORY BOWEL DISEASE WITH AND WITHOUT IBD MEDICATIONS: A COMPARATIVE ANALYSIS
Thota Mo2074 12:30-1:30 p.m. Halls C-E, Lower Level-SDCC AI-ENHANCED PROGNOSTIC MODEL FOR PREDICTING POLYP RECURRENCE AND GUIDING POST-POLYPECTOMY SURVEILLANCE INTERVALS USING THE ERCPMP-V5 DATASET
Thota Mo2075 12:30-1:30 p.m. Halls C-E, Lower Level-SDCC AUTOMATED DETECTION OF GASTROINTESTINAL BLEEDING IN WIRELESS CAPSULE ENDOSCOPY IMAGES USING AUTOENCODERS
Puri Sp892 2-2:22 p.m. 29AB-SDCC A WALK THROUGH THE FUNDAMENTALS OF PRECISION NUTRITION
Bajaj, Obolewicz, Jahagirdar, Thacker, Bush 884 5-5:15 p.m. 6F-SDCC FRAILTY AND HOSPITALIZATION RATES IN AN AMBULATORY COHORT OF PATIENTS WITH CIRRHOSIS: FROM THE NORTH AMERICAN CONSORTIUM FOR THE STUDY OF END-STAGE LIVER DISEASES (NACSELD)
Tuesday, May 6
Name: ID: Time: Location: Title:

Jahagirdar, Arab

983

8:15-8:30 a.m.

6F-SDCC

 SEMAGLUTIDE EXPOSURE IS ASSOCIATED WITH LOWER ODDS OF CIRRHOSIS IN NON-OBESE, NON-DIABETIC PATIENTS WITH STEATOTIC LIVER DISEASE: A GLOBAL DATABASE STUDY

Bastaich, Dahman

1097

10-10:15 a.m.

6C-SDCC

ASSOCIATION OF GLP-1 AGONISTS WITH LIVER-RELATED OUTCOMES AND ALL-CAUSE MORTALITY IN PATIENTS WITH HARMFUL ALCOHOL USE

 

Fakhoury

Tu1028

12:30-1:30 p.m.

Halls C-E, Lower Level-SDCC

A SINGLE-CENTER EXPERIENCE IN ENDOSCOPIC SUBMUCOSAL DISSECTION FOR LESIONS MORE THAN 10 CM IN EGYPT: OUTCOMES AND SAFETY

Jahagirdar, Ali

Tu1090

12:30-1:30 p.m.

Halls C-E, Lower Level-SDCC

EFFICACY OF TOPICAL EPINEPHRINE WITH OR WITHOUT RECTAL INDOMETHACIN TO PREVENT POST-ERCP PANCREATITIS, AND ASSESSING HIGH RISK POPULATION: A SYSTEMATIC REVIEW AND META-ANALYSIS

Bajaj

Tu1507

12:30-1:30 p.m.

Halls C-E, Lower Level-SDCC

MACHINE LEARNING IMPROVES MORTALITY PREDICTION IN A PROSPECTIVELY ENROLLED WORLDWIDE COHORT OF >7700 PATIENTS HOSPITALIZED WITH CIRRHOSIS

Dahiya, Jahagirdar

Tu1538

12:30-1:30 p.m.

Halls C-E, Lower Level-SDCC

DISPARITIES AND TRENDS IN LIVER CANCER INCIDENCE AND MORTALITY ACROSS THE UNITED STATES

Bajaj, DiazGranados

Tu1590

12:30-1:30 p.m.

Halls C-E, Lower Level-SDCC

A NATIONAL SURVEY SHOWS SKEPTICISM ABOUT THE UTILITY OF SBP PROPHYLAXIS AMONG US-BASED HEPATOLOGY PROFESSIONALS

Fakhoury

Tu1606

12:30-1:30 p.m.

Halls C-E, Lower Level-SDCC

THE ROLE OF STATINS AS A TREATMENT FOR PORTAL HYPERTENSION IN CIRRHOSIS: A SYSTEMATIC REVIEW AND META-ANALYSIS

Bajaj, Bush, Thacker

Tu1624

12:30-1:30 p.m.

Halls C-E, Lower Level-SDCC

CHRONIC KIDNEY DISEASE IN HOSPITALIZED PATIENTS WITH CIRRHOSIS, A GLOBAL PERSPECTIVE

Arab

Tu1628

12:30-1:30 p.m.

Halls C-E, Lower Level-SDCC

REASSESSMENT OF LIVER DISEASE CLASSIFICATION AND OUTCOMES POST-TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT (TIPS) PROCEDURE IN A NORTH AMERICAN TERTIARY CARE CENTER: A RETROSPECTIVE COHORT STUDY

Bajaj, Fagan, Snyder

Tu1635

12:30-1:30 p.m.

Halls C-E, Lower Level-SDCC

PTSD AND CIRRHOSIS HAVE UNIQUE IMPACTS ON COGNITION AND PATIENT-REPORTED OUTCOMES IN VETERANS SUGGESTING A MODEL FOR GUIDING THERAPIES IN PATIENTS WITH OVERLAPPING DIAGNOSES

Banini

5450

2-3:30 p.m.

20A-SDCC

EPIDEMIOLOGY AND IMPLEMENTATION OF GUIDELINES IN COMMON GI DISORDERS: COSTS AND BENEFITS

Arab

Sp1184

2-2:18 p.m.

24-SDCC

HEPATIC DISEASES

Connect with us